Combination Therapy with Anti–CTL Antigen-4 and Anti-4-1BB Antibodies Enhances Cancer Immunity and Reduces Autoimmunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination Therapy with Anti–CTL Antigen-4 and Anti-4-1BB Antibodies Enhances Cancer Immunity and Reduces Autoimmunity

Published:2006-07-15 Issue:14 Volume:66 Page:7276-7284
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Kocak Ergun,Lute Kenneth,Chang Xing,May Kenneth F.,Exten Katie R.,Zhang Huiming,Abdessalam Shahab F.,Lehman Amy M.,Jarjoura David,Zheng Pan,Liu Yang

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bi-specific antibody engagers for cancer immunotherapy;2024-08-01

2. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

3. The role of KLRG1: a novel biomarker and new therapeutic target;Cell Communication and Signaling;2024-06-19

4. Aptamers combined with immune checkpoints for cancer detection and targeted therapy: A review;International Journal of Biological Macromolecules;2024-03

5. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors;Journal for ImmunoTherapy of Cancer;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP